Positive Development Fuels Nationwide Autism Care Expansion with $45M Growth Facility
January 16, 2026, 9:39 am
Location: United States
Employees: 501-1000
Founded date: 2019
Total raised: $45M
Positive Development secured $45M from SVB and Pinegrove Venture Partners. This growth facility fuels nationwide expansion of developmental therapy and autism diagnostics. The McLean, Virginia firm targets new markets, strategic acquisitions, and increased family access to vital care via health plans. It champions a lower-cost, relationship-based autism treatment model, boosting access across the U.S. This funding marks a pivotal step in expanding critical children's health services.
Positive Development has secured substantial new financing. A growth debt facility of up to $45 million now strengthens its balance sheet. This capital infusion arrives from Silicon Valley Bank (SVB) and Pinegrove Venture Partners. The funding is strategic. It refinances existing debt. It also provides flexible, non-dilutive capital for future growth.
The McLean, Virginia-based company has clear objectives. Funds will fuel nationwide expansion. New U.S. markets will gain access to services. Existing operational geographies will also see growth. Strategic acquisitions are a key part of this plan. The company aims to broaden access to care. This includes expanding partnerships with commercial insurance and Medicaid health plans. Families across the country stand to benefit.
Positive Development specializes in developmental therapy. It also provides crucial autism diagnostics. Its approach is distinct. The company employs a developmental relationship-based therapy model. This model delivers autism care. It emphasizes lower intensity treatment. It also prioritizes lower costs. Outcomes measurement and evaluation are central to its methodology. This ensures effective, efficient care.
The demand for autism services remains high. Families often face limited options. Accessibility can be a major barrier. High costs present additional challenges. Positive Development aims to bridge these gaps. Its model seeks to offer effective care more widely. This significantly impacts families needing specialized support.
This new financing follows recent successes. Positive Development completed a $51.5 million Series C raise. This prior funding demonstrated investor confidence. The company has also expanded key health plan relationships. Partnerships include Anthem Blue Cross and Blue Shield. Oklahoma Complete Health also joined its network. These collaborations enhance patient access. They solidify the company's market position.
The Developmental Relationship-Based Interventions (DRBI) model is core to Positive Development’s offering. It is designed to foster emotional growth. It builds communication skills. This comprehensive approach supports holistic development. It contrasts with purely behavioral models. Its lower-intensity nature can be less taxing. It also often proves more cost-effective for families and payers.
Investing in autism therapy yields significant returns. Early intervention improves long-term outcomes for children. It reduces societal costs over time. This new capital allows Positive Development to reach more children earlier. It helps them unlock their full potential. This improves overall family well-being.
The company envisions widespread availability of its high-quality therapy. Its goal is to reach families in every state. Payer status should not be a barrier to essential care. This expansion pushes toward that vision. It makes specialized autism care more equitable. It creates a more inclusive healthcare landscape.
Such substantial investment reflects market confidence. Investors see value in Positive Development’s model. They recognize the critical need for its services. This funding validates its integrated approach. It underscores the potential for sustainable growth in the specialized healthcare sector.
Silicon Valley Bank maintains a strong relationship with Positive Development. Their continued support is crucial. It signifies belief in the company's leadership. It also affirms the clinical efficacy of its model. Pinegrove Venture Partners joins this commitment. Their collective backing ensures a robust financial foundation for expansion.
The healthcare industry increasingly seeks innovative solutions. It needs models that combine quality with affordability. Positive Development exemplifies this trend. Its focus on evidence-based, cost-conscious care positions it strongly. This competitive advantage supports its leadership in developmental therapy.
This $45 million growth facility is transformative. It empowers Positive Development to accelerate its mission. It expands critical developmental therapy and autism diagnostics. It increases access for families across the United States. This marks a significant milestone in delivering specialized children's health services. It sets a new standard for accessibility and outcomes in autism care. The future looks promising for children and families seeking effective support.
Positive Development has secured substantial new financing. A growth debt facility of up to $45 million now strengthens its balance sheet. This capital infusion arrives from Silicon Valley Bank (SVB) and Pinegrove Venture Partners. The funding is strategic. It refinances existing debt. It also provides flexible, non-dilutive capital for future growth.
The McLean, Virginia-based company has clear objectives. Funds will fuel nationwide expansion. New U.S. markets will gain access to services. Existing operational geographies will also see growth. Strategic acquisitions are a key part of this plan. The company aims to broaden access to care. This includes expanding partnerships with commercial insurance and Medicaid health plans. Families across the country stand to benefit.
Positive Development specializes in developmental therapy. It also provides crucial autism diagnostics. Its approach is distinct. The company employs a developmental relationship-based therapy model. This model delivers autism care. It emphasizes lower intensity treatment. It also prioritizes lower costs. Outcomes measurement and evaluation are central to its methodology. This ensures effective, efficient care.
The demand for autism services remains high. Families often face limited options. Accessibility can be a major barrier. High costs present additional challenges. Positive Development aims to bridge these gaps. Its model seeks to offer effective care more widely. This significantly impacts families needing specialized support.
This new financing follows recent successes. Positive Development completed a $51.5 million Series C raise. This prior funding demonstrated investor confidence. The company has also expanded key health plan relationships. Partnerships include Anthem Blue Cross and Blue Shield. Oklahoma Complete Health also joined its network. These collaborations enhance patient access. They solidify the company's market position.
The Developmental Relationship-Based Interventions (DRBI) model is core to Positive Development’s offering. It is designed to foster emotional growth. It builds communication skills. This comprehensive approach supports holistic development. It contrasts with purely behavioral models. Its lower-intensity nature can be less taxing. It also often proves more cost-effective for families and payers.
Investing in autism therapy yields significant returns. Early intervention improves long-term outcomes for children. It reduces societal costs over time. This new capital allows Positive Development to reach more children earlier. It helps them unlock their full potential. This improves overall family well-being.
The company envisions widespread availability of its high-quality therapy. Its goal is to reach families in every state. Payer status should not be a barrier to essential care. This expansion pushes toward that vision. It makes specialized autism care more equitable. It creates a more inclusive healthcare landscape.
Such substantial investment reflects market confidence. Investors see value in Positive Development’s model. They recognize the critical need for its services. This funding validates its integrated approach. It underscores the potential for sustainable growth in the specialized healthcare sector.
Silicon Valley Bank maintains a strong relationship with Positive Development. Their continued support is crucial. It signifies belief in the company's leadership. It also affirms the clinical efficacy of its model. Pinegrove Venture Partners joins this commitment. Their collective backing ensures a robust financial foundation for expansion.
The healthcare industry increasingly seeks innovative solutions. It needs models that combine quality with affordability. Positive Development exemplifies this trend. Its focus on evidence-based, cost-conscious care positions it strongly. This competitive advantage supports its leadership in developmental therapy.
This $45 million growth facility is transformative. It empowers Positive Development to accelerate its mission. It expands critical developmental therapy and autism diagnostics. It increases access for families across the United States. This marks a significant milestone in delivering specialized children's health services. It sets a new standard for accessibility and outcomes in autism care. The future looks promising for children and families seeking effective support.